ChronoScale Holdings Corporation (CHRN)
| Market Cap | 1.99B +14,029.9% |
| Revenue (ttm) | 96.37M -15.1% |
| Net Income | -81.67M |
| EPS | -0.58 |
| Shares Out | 145.64M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 160,248 |
| Open | 13.08 |
| Previous Close | 13.03 |
| Day's Range | 13.08 - 14.00 |
| 52-Week Range | 3.50 - 30.00 |
| Beta | 0.98 |
| Analysts | Strong Buy |
| Price Target | 28.50 (+108.33%) |
| Est. Earnings | Nov 19, 2026 |
About CHRN
ChronoScale Holdings Corporation designs and develops a compute platform to support artificial intelligence (AI) workloads in the United States. The company focuses on large-scale deployments and provides dedicated compute environments engineered for performance, consistency, and long-term operational execution. It also provides graphics processing units; computing solutions; AI; machine learning; and high-performance computing solutions. It serves artificial intelligence and machine learning developers. The company was formerly known as Chrono... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for CHRN stock is "Strong Buy." The 12-month stock price target is $28.5, which is an increase of 108.33% from the latest price.
News
ChronoScale initiated with a Buy at Compass Point
Compass Point initiated coverage of ChronoScale (CHRN) with a Buy rating and $25 price target
ChronoScale Reports Fiscal First Quarter 2027 Results
MENLO PARK, Calif., Oct. 15, 2026 (GLOBE NEWSWIRE) -- ChronoScale Holdings Corporation (NASDAQ: CHRN) (“ChronoScale” or the “Company”), an accelerated compute platform purpose-built to support demandi...
ChronoScale falls -14.0%
ChronoScale (CHRN) is down -14.0%, or -$2.08 to $12.80.
ChronoScale falls -13.5%
ChronoScale (CHRN) is down -13.5%, or -$2.42 to $15.46.
ChronoScale falls -13.0%
ChronoScale (CHRN) is down -13.0%, or -$2.33 to $15.55.
ChronoScale files $500M mixed securities shelf
16:58 EDT ChronoScale (CHRN) files $500M mixed securities shelf
Wandercraft Acquires Ekso Bionics, Uniting Two Pioneers to Advance and Expand Robotic Mobility
NEW YORK and SAN RAFAEL, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Wandercraft today announced the acquisition of Ekso Bionics, Inc. from a subsidiary of ChronoScale Holdings Corporation (Nasdaq: CHRN...
ChronoScale announces customer agreements amd sale of Ekso Bionics business
ChronoScale (CHRN) announced an expansion of an existing customer agreement and a separate agreement with a new customer, that increases the scale of its contracted AI infrastructure deployments and s...
ChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit
Expanded agreement with an existing AI infrastructure customer and new customer agreement increases contracted deployment pipeline and is expected to drive Company annualized revenue run rate to $1 bi...
Northland starts four new neocloud names at Outperform
As previously reported, Northland initiated coverage of Boost Run (BRUN), Iren (IREN), ChronoScale (CHRN) and SharonAI (SHAZ), all with Outperform ratings and respective price targets of $36, $99, $32...
ChronoScale initiated with an Outperform at Northland
Northland initiated coverage of ChronoScale (CHRN) with an Outperform rating and $32 price target
ChronoScale Stock (CHRN) Soars 11% on a 50-Megawatt AI Data Center Deal with Microsoft (MSFT)
ChronoScale stock was up on Thursday after the company announced a deal with Microsoft to develop a new AI data center.
ChronoScale announces plans with Microsoft for 50-megawatt AI compute deployment
ChronoScale (CHRN) announced plans with Microsoft (MSFT) for a 50-megawatt AI compute deployment in North America. The deployment will feature Nvidia (NVDA) GB300 NVL72 systems and advanced liquid-coo...
ChronoScale Announces AI Infrastructure Partnership with Microsoft for 50 MW AI Compute Deployment in North America
MENLO PARK, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ChronoScale Corporation (NASDAQ: CHRN), (“ChronoScale” or the “Company”), an accelerated compute platform purpose-built to support demanding artif...
Nutanix, ChronoScale enter strategic partnership
Nutanix (NTNX) and ChronoScale (CHRN) announced a strategic partnership to jointly deliver enterprise-ready AI infrastructure and help accelerate adoption of AI services across global markets. The par...
Nutanix and ChronoScale Announce Strategic Partnership to Accelerate Enterprise AI Adoption
Nutanix and ChronoScale plan to integrate their platforms so enterprises can extend into ChronoScale GPU-as-a-Service, pre-paid inference tokens through ChronoScale Token Factory, and a locally-deploy...
ChronoScale falls -10.7%
ChronoScale (CHRN) is down -10.7%, or -$3.08 to $25.81.
ChronoScale falls -19.5%
ChronoScale (CHRN) is down -19.5%, or -$5.78 to $23.85.
ChronoScale falls -18.5%
ChronoScale (CHRN) is down -18.5%, or -$5.48 to $24.15.
ChronoScale Holdings Registration statement: Registration filing
ChronoScale Holdings filed a registration statement on July 10, 2026, providing details about a securities offering with the SEC.
ChronoScale falls -17.9%
ChronoScale (CHRN) is down -17.9%, or -$3.97 to $18.25.
ChronoScale Holdings Registration statement: Registration filing
ChronoScale Holdings filed a registration statement on June 30, 2026, providing details about a securities offering with the SEC.
ChronoScale Appoints Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer to Accelerate Global AI Infrastructure Strategy
DALLAS, June 04, 2026 (GLOBE NEWSWIRE) -- ChronoScale Corporation (NASDAQ: CHRN) (“ChronoScale” or the “Company”), an accelerated compute platform purpose-built to support demanding artificial intelli...